提高黄素生物可用性的积极向策略:系统性审查
Yun-Shan Wei1, Kun-Lun Liu1, Kun Feng2
1College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China.
Foods (Basel, Switzerland)
|October 16, 2025
概括
黄素 (CUR) 显示出有前途的治疗效果,但其生物可用性较差. 纳米,使用积极向策略,旨在改善药物输送,以更好地治疗癌症和肠道疾病.
科学领域:
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 黄素 (CUR) 对各种癌症和肠道疾病具有显著的治疗潜力.
- 较差的水溶性,化学不稳定性和较低的生物可用性限制了CUR的临床疗效.
- 纳米素配方增强了溶解性和透性,但往往缺乏疾病特异性向,导致在非向组织中积累.
研究的目的:
- 审查纳米素输送的活跃准策略的最新进展.
- 专注于用于肠外病理的受体介导向和用于肠道疾病的结肠特异向.
- 批判性地评估验证纳米素有效性的方法,并讨论局限性和未来的应用.
主要方法:
- 对纳米库尔库的活跃向策略的最新文献的审查.
- 对外肠道疾病的受体介导细胞向的分析.
- 检查肠道疾病的结肠特异性带导向输送.
- 对纳米库尔库明配方的当前验证方法进行批判性审查.
主要成果:
- 积极向策略,包括受体介导和带导向的方法,显示出改善纳米素输送的希望.
- 工程化纳米可以增强疾病特异性热带性,潜在地减少非标组织中的积累.
- 目前的验证方法正在完善,以准确评估向纳米的疗效.
结论:
- 积极向是克服传统纳米素配方局限性的关键策略.
- 向纳米库具有显著的潜力,可以改善肠道和肠外病理的治疗结果.
- 进一步的研究和精细的验证方法对于纳米库尔库明疗法的成功临床转化至关重要.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
177
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
177
Bioavailability Enhancement: Drug Permeability Enhancement
184
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
184
Bioavailability Enhancement: Drug Solubility Enhancement
218
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
218
Bioavailability: Influencing Factors
334
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
334
Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K


